Mount Sinai Health System — New York, New York

Mount Sinai Health System is a clinical research site located in New York, New York, United States 10029.

Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Mount Sinai Health System has participated in 39 clinical trials with 19 currently active.

Therapeutic areas: Multiple Myeloma, Endometrial Adenocarcinoma, Nodule Solitary Pulmonary.

Sponsors: Icahn School of Medicine at Mount Sinai, Acrivon Therapeutics, Biodesix, Inc..

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Health System?

Mount Sinai Health System has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Health System conducted?

Mount Sinai Health System has 39 clinical trials on record, with 19 currently active. Their work covers Multiple Myeloma, Endometrial Adenocarcinoma, Nodule Solitary Pulmonary.

Is Mount Sinai Health System accredited by Crixeo Clinical Trials?

Mount Sinai Health System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai Health System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.